3004.90.92.16 - Containing metoprolol or its salts 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS classification covers pharmaceutical preparations specifically containing metoprolol or its salts. Metoprolol is a beta-blocker medication commonly prescribed for the treatment of various cardiovascular conditions such as hypertension (high blood pressure), angina (chest pain), and certain heart rhythm disorders. These medicaments are formulated for therapeutic or prophylactic use and are presented in measured doses or forms suitable for retail sale, aligning with the broader scope of heading 3004 for medicaments.
This category is distinguished from its sibling categories by the specific active pharmaceutical ingredient. For instance, 3004.90.92.17 pertains to medicaments containing amiodarone, while 3004.90.92.18 covers those with diltiazem, and 3004.90.92.19 relates to hydralazine. The primary differentiator is the chemical identity of the contained therapeutic substance.
As this node is a leaf node, there are no further subcategories within 3004.90.92.16. Classification at this level is determined by the presence of metoprolol or its salts as the active ingredient in a medicament packaged for direct therapeutic or prophylactic application.